Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass

J Cardiothorac Vasc Anesth. 2005 Jun;19(3):294-9. doi: 10.1053/j.jvca.2005.03.004.

Abstract

Objective: The purpose of this study was to determine if patients receiving statin therapy before coronary artery bypass grafting surgery would have less cognitive dysfunction after cardiopulmonary bypass as a consequence of a diminished inflammatory response.

Design: Retrospective observational study of patients undergoing coronary artery bypass grafting surgery.

Setting: Referral center for cardiothoracic surgery at a university hospital.

Participants: Four hundred forty patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass.

Interventions: None.

Measurements and main results: Thirty-five percent of patients received statins in the preoperative period. Multivariable analysis revealed no effect of preoperative statin therapy on cognitive function (p = 0.67). Post hoc analysis revealed that statin therapy at hospital discharge was associated with less improvement in cognitive performance at 6 weeks after surgery (p = 0.011). No significant differences were found between statin therapy groups in either range or maximum value of any of the cytokines (p > 0.05).

Conclusions: Preoperative statin therapy did not decrease the inflammatory response to cardiopulmonary bypass or the cognitive dysfunction commonly seen after cardiac surgery.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • C-Reactive Protein / drug effects
  • Cardiopulmonary Bypass / adverse effects*
  • Cognition Disorders / drug therapy
  • Cognition Disorders / etiology*
  • Cognition Disorders / prevention & control*
  • Coronary Artery Bypass / adverse effects
  • Coronary Artery Bypass / methods
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Inflammation / drug therapy
  • Interleukin-2 Receptor alpha Subunit
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control*
  • Preoperative Care / methods*
  • Receptors, Interleukin / blood
  • Receptors, Interleukin / drug effects
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Failure
  • Tumor Necrosis Factor-alpha / drug effects

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • IL2RA protein, human
  • Interleukin-2 Receptor alpha Subunit
  • Interleukin-6
  • Receptors, Interleukin
  • Tumor Necrosis Factor-alpha
  • C-Reactive Protein